All Stories

  1. Acute pancreatitis caused by dapagliflozin and other drugs in the SGLT2 inhibitor class.

    Article • Diabetes Spectrum, September 2021, American Diabetes Association

    Jeremy Johnson

  2. The role of basal insulin and GLP-1 receptor agonist combination products in the management of type 2 diabetes

    Article • Therapeutic Advances in Endocrinology and Metabolism, April 2018, SAGE Publications

    Jeremy Johnson

  3. Novel Concentrated Insulin Delivery Devices: Developments for Safe and Simple Dose Conversions

    Article • Journal of Diabetes Science and Technology, November 2016, SAGE Publications

    Jeremy Johnson

  4. Barriers to Patient Use of Control Solution for Glucose Meters: Surveys of Patients, Pharmacists, and Providers in a Metropolitan Area

    Article • Journal of Diabetes Science and Technology, November 2016, SAGE Publications

    Jeremy Johnson